EGD并发十二指肠淋巴管扩张的横断面病例对照研究

C. Hui, Kit Hui
{"title":"EGD并发十二指肠淋巴管扩张的横断面病例对照研究","authors":"C. Hui, Kit Hui","doi":"10.17554/j.issn.2224-3992.2020.09.912","DOIUrl":null,"url":null,"abstract":"Background/Aim: Intestinal lymphangiectasia (IL) is associated with co-existing pathology such as autoimmune diseases or tumors. It can also be incidentally found on esophagogastroduodenoscopy (EGD). However, the clinical significance of this finding is still uncertain. The aim of this study is to determine if those with incidental finding of IL on EGD have a higher risk of co-existing pathology. Methods: This is a cross-sectional case-controlled study. A total of 4948 patients underwent EGD. Results: One-hundred and twenty seven of these 4948 patients (2.6%) had histologically confirmed IL (IL group). Seven hundred and six patients without IL on EGD performed in the same session as those with IL were recruited as control (Control group). Twenty-two of the 127 patients (17.3%) in the IL group had co-existing pathology when compared with 54 of the 706 patients (7.6%) in the Control group (p = 0.001). Patients with co-existing pathology were more likely to have IL in the duodenum [22/76 (28.9%) vs. 105/757 (13.9%), p = 0.001], be older in age [median (range) 56 (34-79) years vs. 53 (21-82) years, p = 0.015], have a higher serum erythrocyte sedimentation rate [median (range) 19 (3-108) mm/hr vs. 15 (1-96) mm/hr, p < 0.001)] and to have an elevated serum erythrocyte sedimentation rate [21/76 (27.6%) vs. 56/757 (7.4%), p < 0.001] when compared with patients without co-existing pathology. On multiple analyses, IL in the duodenum [p = 0.036, Odds Ratio 1.043, 95% confidence interval 0.925-1.175] was an independent factor associated with co-existing pathology. Conclusion: Those with IL are more likely to have co-existing pathology.","PeriodicalId":90217,"journal":{"name":"Journal of gastroenterology and hepatology research","volume":"9 1","pages":"3128-3133"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Cross-sectional Case-controlled Study on the Significance of Intestinal Lymphangiectasia Incidentally found in the Duodenum on EGD\",\"authors\":\"C. Hui, Kit Hui\",\"doi\":\"10.17554/j.issn.2224-3992.2020.09.912\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background/Aim: Intestinal lymphangiectasia (IL) is associated with co-existing pathology such as autoimmune diseases or tumors. It can also be incidentally found on esophagogastroduodenoscopy (EGD). However, the clinical significance of this finding is still uncertain. The aim of this study is to determine if those with incidental finding of IL on EGD have a higher risk of co-existing pathology. Methods: This is a cross-sectional case-controlled study. A total of 4948 patients underwent EGD. Results: One-hundred and twenty seven of these 4948 patients (2.6%) had histologically confirmed IL (IL group). Seven hundred and six patients without IL on EGD performed in the same session as those with IL were recruited as control (Control group). Twenty-two of the 127 patients (17.3%) in the IL group had co-existing pathology when compared with 54 of the 706 patients (7.6%) in the Control group (p = 0.001). Patients with co-existing pathology were more likely to have IL in the duodenum [22/76 (28.9%) vs. 105/757 (13.9%), p = 0.001], be older in age [median (range) 56 (34-79) years vs. 53 (21-82) years, p = 0.015], have a higher serum erythrocyte sedimentation rate [median (range) 19 (3-108) mm/hr vs. 15 (1-96) mm/hr, p < 0.001)] and to have an elevated serum erythrocyte sedimentation rate [21/76 (27.6%) vs. 56/757 (7.4%), p < 0.001] when compared with patients without co-existing pathology. On multiple analyses, IL in the duodenum [p = 0.036, Odds Ratio 1.043, 95% confidence interval 0.925-1.175] was an independent factor associated with co-existing pathology. Conclusion: Those with IL are more likely to have co-existing pathology.\",\"PeriodicalId\":90217,\"journal\":{\"name\":\"Journal of gastroenterology and hepatology research\",\"volume\":\"9 1\",\"pages\":\"3128-3133\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-04-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of gastroenterology and hepatology research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17554/j.issn.2224-3992.2020.09.912\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of gastroenterology and hepatology research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17554/j.issn.2224-3992.2020.09.912","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景/目的:肠淋巴管扩张症(IL)与自身免疫性疾病或肿瘤等共存病理有关。它也可以在食管胃十二指肠镜检查(EGD)中偶然发现。然而,这一发现的临床意义仍不确定。本研究的目的是确定那些在EGD上偶然发现IL的人是否有更高的合并病理风险。方法:这是一项横断面病例对照研究。共有4948名患者接受了EGD。结果:4948例患者中有127例(2.6%)经组织学证实为IL(IL组)。在与有IL的患者在同一疗程中进行的EGD中没有IL的706名患者被招募为对照组(对照组)。与对照组706名患者中的54名(7.6%)相比,IL组127名患者中有22名(17.3%)同时存在病理(p=0.001)。同时存在病理的患者十二指肠更有可能存在IL[22/76(28.9%)vs.105/757(13.9%),p=0.001],年龄更大[中位(范围)56(34-79)岁vs.53(21-82)岁,p=0.015],与没有共同存在病理的患者相比,具有更高的血清红细胞沉降率[中位数(范围)19(3-108)mm/hr对15(1-96)mm/hr,p<0.001)],并且具有升高的血清红血沉率[21/76(27.6%)对56/757(7.4%),p<0.001]。在多项分析中,十二指肠中的IL[p=0.036,比值比1.043,95%置信区间0.925-1.175]是与共存病理相关的独立因素。结论:IL患者更有可能同时存在病理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A Cross-sectional Case-controlled Study on the Significance of Intestinal Lymphangiectasia Incidentally found in the Duodenum on EGD
Background/Aim: Intestinal lymphangiectasia (IL) is associated with co-existing pathology such as autoimmune diseases or tumors. It can also be incidentally found on esophagogastroduodenoscopy (EGD). However, the clinical significance of this finding is still uncertain. The aim of this study is to determine if those with incidental finding of IL on EGD have a higher risk of co-existing pathology. Methods: This is a cross-sectional case-controlled study. A total of 4948 patients underwent EGD. Results: One-hundred and twenty seven of these 4948 patients (2.6%) had histologically confirmed IL (IL group). Seven hundred and six patients without IL on EGD performed in the same session as those with IL were recruited as control (Control group). Twenty-two of the 127 patients (17.3%) in the IL group had co-existing pathology when compared with 54 of the 706 patients (7.6%) in the Control group (p = 0.001). Patients with co-existing pathology were more likely to have IL in the duodenum [22/76 (28.9%) vs. 105/757 (13.9%), p = 0.001], be older in age [median (range) 56 (34-79) years vs. 53 (21-82) years, p = 0.015], have a higher serum erythrocyte sedimentation rate [median (range) 19 (3-108) mm/hr vs. 15 (1-96) mm/hr, p < 0.001)] and to have an elevated serum erythrocyte sedimentation rate [21/76 (27.6%) vs. 56/757 (7.4%), p < 0.001] when compared with patients without co-existing pathology. On multiple analyses, IL in the duodenum [p = 0.036, Odds Ratio 1.043, 95% confidence interval 0.925-1.175] was an independent factor associated with co-existing pathology. Conclusion: Those with IL are more likely to have co-existing pathology.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Changing liver stiffness predict regression in advanced fibrosis patients with chronic hepatitis B, but not in moderate fibrosis patients Effect of Zangfu ointment and massage therapy on functional constipation: a protocol for a randomised controlled trial Classification of metabolic-associated fatty liver disease subtypes based on TCM clinical phenotype A review on conventional and herbal drug approach to peptic ulcer Efficacy and safety of Banxia Xiexin Decoction in the treatment of gastric ulcer: a systematic review and meta-analysis of twenty-seven randomized controlled trials
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1